相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Concordance among gene-expression-based predictors for breast cancer
Cheng Fan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
The molecular portraits of breast tumors are conserved across microarray platforms
Zhiyuan Hu et al.
BMC GENOMICS (2006)
Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer
DA Berry et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer
JA Foekens et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Gene expression profiling of breast cell lines identifies potential new basal markers
E Charafe-Jauffret et al.
ONCOGENE (2006)
Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas
SM Rodríguez-Pinilla et al.
CLINICAL CANCER RESEARCH (2006)
The impact of expression profiling on prognostic and predictive testing in breast cancer
JS Reis et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors
V Guarneri et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling
SJ Van Laere et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma
CA Livasy et al.
MODERN PATHOLOGY (2006)
Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells
GE Konecny et al.
CANCER RESEARCH (2006)
Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: A prospective cohort study
R Suzuki et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer
B Weigelt et al.
CANCER RESEARCH (2005)
High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses
DM Abd El-Rehim et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Breast cancer molecular subtypes respond differently to preoperative chemotherapy
R Rouzier et al.
CLINICAL CANCER RESEARCH (2005)
Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily pretreated patients with metastatic carcinomas
HA Burris et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Folate intake and risk of breast cancer characterized by hormone receptor status
SM Zhang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Genes that mediate breast cancer metastasis to lung
AJ Minn et al.
NATURE (2005)
Limits of predictive models using microarray data for breast cancer clinical treatment outcome
JF Reid et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status
SF Marshall et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Ethnicity and breast cancer: Factors influencing differences in incidence and outcome
RT Chlebowski et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival
HY Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancer
S Modi et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Risk factors for breast cancer according to estrogen and progesterone receptor status
GA Colditz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma
WY Chen et al.
CANCER (2004)
Conservation of breast cancer molecular subtypes and transcriptional patterns of tumor progression across distinct ethnic populations
K Yu et al.
CLINICAL CANCER RESEARCH (2004)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Predicting early failure after adjuvant chemotherapy in high-risk breast cancer patients with extensive lymph node involvement
IF Faneyte et al.
CLINICAL CANCER RESEARCH (2004)
The role of BRCA1 in the cellular response to chemotherapy
RD Kennedy et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Cell-type-specific responses to chemotherapeutics in breast cancer
MA Troester et al.
CANCER RESEARCH (2004)
KIT (CD117)-positive breast cancers are infrequent and lack KIT gene mutations
R Simon et al.
CLINICAL CANCER RESEARCH (2004)
A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen
XJ Ma et al.
CANCER CELL (2004)
Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2
MC King et al.
SCIENCE (2003)
Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer
WD Foulkes et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
C Sotiriou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Design of studies using DNA microarrays
R Simon et al.
GENETIC EPIDEMIOLOGY (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer
PM Ravdin et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptors
M Colleoni et al.
ANNALS OF ONCOLOGY (2000)
分享论文
